American Shared Hospital Services (NYSEAMERICAN:AMS) Short Interest Update

American Shared Hospital Services (NYSEAMERICAN:AMS) was the target of a large drop in short interest in September. As of September 15th, there was short interest totaling 5,436 shares, a drop of 53.2% from the August 31st total of 11,622 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average trading volume of 10,354 shares, the days-to-cover ratio is currently 0.5 days.

American Shared Hospital Services Trading Up 0.7%

Shares of NYSEAMERICAN:AMS traded up $0.01 on Tuesday, reaching $1.44. The company had a trading volume of 1,248 shares, compared to its average volume of 8,697. The firm has a market capitalization of $9.58 million, a PE ratio of -5.76 and a beta of 0.30. American Shared Hospital Services has a 52-week low of $1.25 and a 52-week high of $2.98. The firm’s 50 day simple moving average is $1.48 and its 200-day simple moving average is $1.51.

American Shared Hospital Services (NYSEAMERICAN:AMS) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.05). American Shared Hospital Services had a negative return on equity of 6.52% and a negative net margin of 5.83%.The company had revenue of $8.43 million for the quarter, compared to analysts’ expectations of $7.56 million. As a group, equities research analysts predict that American Shared Hospital Services will post -0.14 earnings per share for the current year.

American Shared Hospital Services Company Profile

American Shared Hospital Services (NYSEAMERICAN: AMS) is a healthcare services and medical technology company that provides hospitals and medical centers with access to advanced equipment and related services. Its business model is designed to help healthcare providers offer specialized treatments without bearing the full cost and operational responsibility of purchasing and managing complex medical technology.

The company has historically focused on radiation oncology and stereotactic radiosurgery, including Gamma Knife systems used in the treatment of brain disorders and tumors.